Knowledge, attitudes and perceptions regarding lymphatic filariasis: study on systematic noncompliance with mass drug administration

被引:5
|
作者
Cabral, Silvia [1 ]
Bonfim, Cristine [2 ,3 ]
Oliveira, Rosalira [2 ]
Oliveira, Paula [4 ,5 ]
Guimaraes, Terezinha [4 ]
Brandao, Eduardo [5 ]
Aguiar-Santos, Ana Maria [5 ]
Medeiros, Zulma [5 ,6 ]
机构
[1] Fundacao Oswaldo Cruz, Ctr Pesquisa Aggeu Magalhaes, Programa Doutorado Saude Publ, Recife, PE, Brazil
[2] Fundacao Joaquim Nabuco, Dept Pesquisa Social, Recife, PE, Brazil
[3] Univ Fed Pernambuco, Programa Posgrad Integrada Saude Colet, Recife, PE, Brazil
[4] Secretaria Saude Olinda, Recife, PE, Brazil
[5] Fundacao Oswaldo Cruz, Ctr Pesquisa Aggeu Magalhaes, Dept Parasitol, Recife, PE, Brazil
[6] Univ Pernambuco, Inst Ciencias Biol, Recife, PE, Brazil
关键词
Lymphatic filariasis; Control program; Mass drug administration; Systematic noncompliance; URBAN AREAS; EPIDEMIOLOGIC SITUATION; BANCROFTIAN FILARIASIS; ENDEMIC AREA; PROGRAM; ELIMINATION; COVERAGE; BRAZIL; INDIA; DISTRICT;
D O I
10.1590/S1678-9946201759023
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The aim of this study was to investigate the epidemiological characteristics, antigenic profile, perceptions, attitudes and practices of individuals who have been systematically noncompliant in mass drug administration (MDA) campaigns targeting lymphatic filariasis, in the municipality of Olinda, State of Pernambuco, Northeastern Brazil. A pretested questionnaire was used to obtain information on socioenvironmental demographics, perceptions of lymphatic filariasis and MDA, and reasons for systematic noncompliance with treatment. A rapid immunochromatographic test (ICT) was performed during the survey to screen for filariasis. It was found that the survey subjects knew about filariasis and MDA. Filariasis was identified as a disease (86.2%) and 74.4% associated it with the presence of swelling in the legs. About 80% knew about MDA, and the main source of information was healthcare workers (68.3%). For men the main reasons for systematic noncompliance with MDA were that "the individual had not received the medication" (p=0.03) and for women "the individual either feared experiencing adverse reactions". According to the ICT, the prevalence of lymphatic filariasis was 2%. The most important causes of systematic noncompliance were not receiving the drug and fear of side-effects. For successful implementation of MDA programs, good planning, educational campaigns promoting the benefits of MDA, adoption of measures to minimize the impact of adverse effects and improvement of drug distribution logistics are needed.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] The effect of compliance on the impact of mass drug administration for elimination of lymphatic filariasis in Egypt
    El-Setouhy, Maged
    Elaziz, Khaled M. Abd
    Helmy, Hanan
    Farid, Hoda A.
    Kamal, Hussein A.
    Ramzy, Reda M. R.
    Shannon, William D.
    Weil, Gary J.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2007, 77 (06): : 1069 - 1073
  • [42] A systematic review of factors that shape implementation of mass drug administration for lymphatic filariasis in sub-Saharan Africa
    Adam Silumbwe
    Joseph Mumba Zulu
    Hikabasa Halwindi
    Choolwe Jacobs
    Jessy Zgambo
    Rosalia Dambe
    Mumbi Chola
    Gershom Chongwe
    Charles Michelo
    BMC Public Health, 17
  • [43] Knowledge and perceptions about lymphatic filariasis: a study during the programme to eliminate lymphatic filariasis in an urban community of Orissa, India
    Rath, K.
    Nath, N.
    Shaloumy, Mishra
    Swain, B. K.
    Suchismita, Mishra
    Babu, B. K.
    TROPICAL BIOMEDICINE, 2006, 23 (02) : 156 - 162
  • [44] Alternative drug regimens and mass drug administration strategies for lymphatic filariasis and onchocerciasis elimination programmes
    Weil, G. J.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2015, 20 : 28 - 28
  • [45] Mass drug administration for lymphatic filariasis elimination in a coastal state of India: a study on barriers to coverage and compliance
    Hussain, Mohammad A.
    Sitha, Ashok K.
    Swain, Subhashisa
    Kadam, Shridhar
    Pati, Sanghamitra
    INFECTIOUS DISEASES OF POVERTY, 2014, 3
  • [46] Mass drug administration for lymphatic filariasis elimination in a coastal state of India: a study on barriers to coverage and compliance
    Mohammad A Hussain
    Ashok K Sitha
    Subhashisa Swain
    Shridhar Kadam
    Sanghamitra Pati
    Infectious Diseases of Poverty, 3
  • [47] Mass drug treatment for lymphatic filariasis and onchocerciasis
    Molyneux, DH
    Bradley, M
    Hoerauf, A
    Kyelem, D
    Taylor, MJ
    TRENDS IN PARASITOLOGY, 2003, 19 (11) : 516 - 522
  • [48] Systematic sampling of adults as a sensitive means of detecting persistence of lymphatic filariasis following mass drug administration in Sri Lanka
    Rao, Ramakrishna U.
    Samarasekera, Sandhya D.
    Nagodavithana, Kumara C.
    Punchihewa, Manjula W.
    Ranasinghe, Udaya S. B.
    Weil, Gary J.
    PLOS NEGLECTED TROPICAL DISEASES, 2019, 13 (04):
  • [49] Predictors of compliance in mass drug administration for the treatment and prevention of lymphatic filariasis in Leogane, Haiti
    Talbot, Jeffrey T.
    Viall, Abigail
    Direny, Abdel
    de Rochars, Madsen Beau
    Addiss, David
    Streit, Thomas
    Mathieu, Els
    Lammie, Patrick J.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2008, 78 (02): : 283 - 288
  • [50] Are we nearly there yet? Coverage and compliance of mass drug administration for lymphatic filariasis elimination
    Alexander, Neal D. E.
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2015, 109 (03) : 173 - 174